Abstract
The Epstein-Barr virus has been considered a possible pathogen for RA because it is ubiquitous, has profound effects on the immune system [1] and is able to persist in two cell types, lymphoid cells [2] and the salivary gland epithelium [3]. Both of these could envisaged as possible sources for the pathogenic features of RA, either by causing polyclonal activation of B cells, a prominent feature of the disease, or by leading to salivary gland inflammation (as secondary Sjögren’s syndrome). Evidence from cellular studies suggesting possible involvement in RA includes the ability of the virus to induce rheumatoid factor production in vitro and impaired T cell regulation of EBV-infected B cells (see Lotz and Roudier, this volume), and some in vivo studies which suggest increased virus load. A second body of evidence comes from serological studies which have shown increased titres of antibodies to a variety of EBV-encoded antigens. This has been interpreted as suggesting more active EBV infection in RA. However, the results of much of this work must be interpreted with caution, as many of the earlier assays for EBV antibodies were crude, semiquantitative, subject to a variety of artefacts and not always performed with age- and sex-matched controls.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tosato G, Blaese RM (1985) Epstein-Barr virus infection and immunoregulation in man. Adv Immunol 37:99–149
Jondal J, Klein G (1973) Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes. J Exp Med 138:1365–1378
Wolf H, Haus M, Wilmes E (1984) Persistence of Epstein-Barr virus in the parotid gland. J Virol 51:795–798
Pearson GR (1985) Advances in the identification of EBV-specific proteins. In: Levine et al. (eds) Epstein-Barr virus and associated diseases. Nijhoff, Boston
Young LS, Clark D, Sixbey JW, Rickinson AB (1986) Epstein-Barr virus receptors on human pharyngeal cells. Lancet 1:240–242
Yokochi T, Yanagawa A, Kimura Y, Mizushima Y (1989) High titre of antibody to Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 16:1029–1032
Edwards JMB, Woodroof M (1979) EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages. J Clin Pathol 32:1036–1041
Venables PJW, Roffe LM, Erhardt CC, Maini RN, Edwards JMB, Porter AD (1981) Titers of antibodies to RANA in rheumatoid arthritis and normal sera. Arthritis Rheum 24:1459–1464
Ferrei PB, Aitcheson CT, Pearson GR, Tan EM (1981) Seroepidemiological study of relationships between EBV and rheumatoid arthritis. J Clin Invest 67:681–687
Elson CJ, Crawford DM, Bucknall RC, Allen C, Thomson JL, Hall ND, Bacon PA, Epstein MA (1979) Infection with Epstein-Barr virus and rheumatoid arthritis. Lancet 1:105
Gear AJ, Venables PJW, Edwards JMB, Maini RN, Ansell BM (1986) Rheumatoid arthritis, juvenile arthritis, iridocyclitis and the Epstein-Bar virus. Ann Rheum Dis 45:6–8
Catalano MA, Carson DA, Nierderman JC, Feorino P, Vaughan JH (1980) Antibody to rheumatoid arthritis nuclear antigen: its relationship to in vivo Epstein-Barr virus infection. J Clin Invest 65:1238–1242
Bardwick PA, Bluestein HG, Zwaifler NG, Depper JM, Seegmiller JE (1980) Altered regulation of EBV-induced lymphoblast proliferation on rheumatoid arthritis lymphoid cells. Arthritis Rheum 23:626–632
Alspaugh MA, Henle G, Lennette FT, Henle W (1981) Elevated levels of antibodies to EBV antigens in sera and synovial fluid of patients with rheumatoid arthritis. J Clin Invest 67:1134–1140
Tosato G, Steinberg AD, Blaese RM (1981) Defective Epstein-Barr-specific suppressor T cell function in rheumatoid arthritis. N Engl J Med 305:1238–1243
Gaston JSH, Richinson AB, Epstein MA (1982) Epstein-Barr virus-specific cytotoxic T cell responses in rheumatoid arthritis patients. Rheumatol Int 2:155–159
Venables PJW, Ross MGR, Charles PJ, Melsom RD, Griffiths PD, Maini RN (1985) A seroepidemiological study of cytomegalovirus and Epstein-Barr virus in rheumatoid arthritis and sicca syndrome. Ann Rheum Dis 44:742–746
Yao QY, Rickinson AB, Gaston JSH, Epstein MA (1986) Disturbance of Epstein-Barr virus host balance in rheumatoid arthritis patients: a quantitative study. Clin Exp Immunol 64:302–310
Larsen PD, Bloomer LC, Bray PF (1985) Epstein-Barr nuclear antigen and viral capsid antigen antibody titres in multiple sclerosis. Neurology 35:435–438
Yamaoka K, Miyasaka N, Yamamoto K (1988) Possible involvement of Epstein-Barr virus in polyclonal B cell activation in Sjögren’s syndrome. Arthritis Rheum 31:1014–1021
Rhodes G, Carson DA, Valbract J, Houghten R, Vaughan JH (1985) Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. J Immunol 134:211–216
Alspaugh MA, Tan EM (1976) Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Arthritis Rheum 19:711–719
Alspaugh MA, Jensen FC, Rabin H, Tan EM (1978) Lymphocyts transformed by Epstein-Barr virus: induction of nuclear antigen reactive with serum antibody in rheumatoid arthritis. J Exp Med 147:1018–1027
Ng KC, Brown KA, Perry JA, Holborow EJ (1980) Anti-RANA antibody: a marker for seronegative and seropositive rheumatoid arthritis. Lancet 1:447–449
Male D, Young A, Pilkinton C, Sutherland S, Roitt IN (1982) Antibodies to EB virus- and cytomegalovirus-induced antigens in early rheumatoid disease. Clin Exp Immunol 50:341–346
Le Clerk SA, Davis P (1982) Anti-RANA antibody in rheumatoid arthritis, seronegative polyarthritis and normal controls. Rheum Int 1:177–180
Hazelton RA, Cross SM, Robert G, Strachan N (1986) A family study of the prevalence of antibodies to the rheumatoid arthritis nuclear antigen (RANA). Br J Rheumatol 25:349–352
Lydyard PM, Irving WV (1988) Is there a role for Epstein-Barr virus in the aetiology of rheumatoid arthritis? Br J Rheumatol 27 [Suppl] 120–127
Venables PJW (1988) Leading article: Epstein-Barr virus and autoimmunity in rheumatoid arthritis. Ann Rheum Dis 47:265–269
Sculley TB, Pope JH, Hazelton RA (1986) Comparison between the presence of antibodies to Epstein-Barr virus nuclear antigen 2 and the rheumatoid arthritis nuclear antigen in rheumatoid arthritis patients. Arthritis Rheum 29:964–970
Billings PB, Hoch SO, White PJ, Carson DA, Vaughan JH (1983) Antibodies to the Epstein-Barr nuclear antigen and to the rheumatoid arthritis nuclear antigen identify the same polypeptide. Proc Natl Acad Sci USA 80:7104–7108
Venables PJW, Pawlowski T, Mumford PA, Brown C, Crawford DH, Maini RN (1988) Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen-1. Ann Rheum Dis 47:270–279
Baboonian C, Halliday D, Venables PJW, Pawlowski T, Millman G, Maini RN (1989) Antibodies in rheumatoid arthritis react specifically with the glycine alanine repeat sequence of Epstein-Barr nuclear antigen-1. Rheumatol Int 9:161–166
Rhodes G, Rumpold R, Kurki P, Patrick KM, Carson DA, Vaughan JH (1987) Autoantibodies in infectious mononucleosis have specificity for the glycine alanine repeating region of the Epstein-Barr nuclear antigen. J Exp Med 165:1026–1042
Birkenfeld P, Haratz N, Klein G (1990) Cross-reactivity between the EBNA-1 p107 peptide, collagen and keratin: implications for the pathogenesis of rheumatoid arthritis. Clin Immunol Immunopathol 54:14–25
Venables PJW (1989) Infection and rheumatoid arthritis. Curr Opinion Rheumatol 1:15–20
Fox R, Sportsman R, Rhodes G, Luka J, Pearson G, Vaughan JH (1986) Rheumatoid arthritis synovial membrane contains a 62000 molecular wt. protein that shares an antigenic epitope with the Epstein-Barr virus-encoded nuclear antigen. J Clin Invest 77:1539–1547
Garzelli C, Pacciardi A, Carmignani M, Conaldi PG, Basolo F, Falcone G (1989) A human monoclonal antibody isolated from a patient with infectious mononucleosis reactive with both self-antigens and Epstein-Barr nuclear antigen (EBNA). Immunol Lett 22:211
Inman RD, Chiu B, Hamilton NC (1987) Analysis of immune complexes in rheumatoid arthritis reveals cross-reactivity of viral capsid antigen and human IgG. J Immunol 138:407–412
Roudier J, Rhodes G, Petersen J, Vaughan JH, Carson DA (1988) The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR-1 and rheumatoid arthritis. Scand J Immunol 27:367–372
Rowley MJ, Williamson J, Mackay IR (1987) Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis. Arthritis Rheum 12:1420–1426
Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman W (1989) secretion of antibodies to types I and II by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 2:1087–1092
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Venables, P.J.W. (1992). Antibodies to EBV-Encoded Proteins in Rheumatoid Arthritis. In: Smolen, J.S., Kalden, J.R., Maini, R.N. (eds) Rheumatoid Arthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76189-8_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-76189-8_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76191-1
Online ISBN: 978-3-642-76189-8
eBook Packages: Springer Book Archive